| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5832654 | International Immunopharmacology | 2014 | 7 Pages |
Abstract
These results demonstrate that delivery of the Ad-hIFN-λ1 can mitigate allergic airway inflammation in experimental asthma. The potent immunoregulatory action of IFN-λ1 may offer a novel therapeutic approach to treat allergic asthma.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yan Li, Qiaoyan Gao, Xianli Yuan, Mi Zhou, Xiao Peng, Xiaojin Liu, Xiaoxuan Zheng, Damo Xu, Mingcai Li,